Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESIPI for Reducing Perioperative Major Adverse Cardiac Events: A Phase II Prospective Randomized Controlled Trial

NCT03208023 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03208023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03208023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESIPI for Reducing Perioperative Major Adverse Cardiac Events: A Phase II Prospective Randomized Controlled Trial
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
October 9, 2017
Completion date
December 3, 2018
Enrollment
155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac event, fluid management, fluid responsiveness, hemodynamic management, hemodynamic monitoring, inotropy, perioperative cardiac risk, vascular resistance